Analyst Craig Hettenbach of Morgan Stanley maintained a Buy rating on Ardent Health Partners, Inc. (ARDT – Research Report), reducing the price target to $22.00. Craig Hettenbach has given his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback